Table 1.
Indicator | Sample Size | Scores (%) | |||||
---|---|---|---|---|---|---|---|
Visit 1 | Visit 2 | Visit 3 | Visit 4 | Visit 5 | Visit 6 | ||
Infrastructurea | n = 34 | 75.29 ± 20.34 | 76.18 ± 19.85 | 79.12 ± 17.12 | 84.12 ± 13.51 | 87.06 ± 11.94 | 93.82 ± 8.17* |
n = 16b | 56.88 ± 12.50 | 66.88 ± 17.40 | 71.25 ± 15.86 | 83.75 ± 15.86* | 85.63 ± 10.94* | 91.88 ± 9.12* | |
HRHa | n = 34 | 73.15 ± 15.60 | 76.26 ± 16.06 | 74.62 ± 16.03 | 78.56 ± 14.30 | 77.41 ± 15.21 | 81.62 ± 15.19 |
n = 21b | 63.05 ± 8.22 | 72.67 ± 14.59 | 72.29 ± 14.62 | 76.76 ± 14.74 | 76.29 ± 15.39 | 81.95 ± 13.95* | |
Basic equipmenta | n = 34 | 94.18 ± 09.18 | 92.94 ± 10.94 | 95.44 ± 06.97 | 98.15 ± 04.33 | 96.06 ± 06.61 | 97.12 ± 06.24 |
Essential drugsa | n = 34 | 77.21 ± 18.43 | 83.38 ± 14.07 | 83.38 ± 16.95 | 87.50 ± 15.29 | 87.65 ± 12.69 | 90.15 ± 11.71* |
n = 13b | 58.46 ± 14.05 | 79.62 ± 16.52* | 75.38 ± 22.22 | 82.31 ± 18.78* | 82.31 ± 14.23* | 86.54 ± 12.31* | |
HIV screeningc | n = 34 | 84.91 ± 26.39 | 91.82 ± 21.12 | 87.35 ± 24.57 | 94.76 ± 16.05 | 92.71 ± 15.89 | 97.06 ± 11.17 |
n = 8b | 42.88 ± 22.47 | 92.75 ± 24.22* | 92.00 ± 25.18* | 88.13 ± 22.84* | 90.88 ± 17.98* | 99.75 ± 00.71* | |
Routine immunizationc | n = 34 | 97.65 ± 53.06 | 92.18 ± 49.66 | 100.50 ± 53.74 | 116.60 ± 78.16 | 114.90 ± 75.14 | 117.20 ± 76.76 |
Abbreviations: ANOVA, analysis of variance; HRH, human resources for health; ISS, integrated supportive supervision.
aValues marked with an asterisk (*) along rows are significantly different compared with visit 1 (P < .05). The level of significance in mean difference was determined using the Kruskal-Wallis test followed by Dunn post hoc test.
bNumber of facilities with scores of ≤70% after the first visit.
cValues marked with an asterisk (*) along rows are significantly different compared with visit 1 (P < .05). The level of significance in mean difference was determined using ANOVA followed by Tukey post hoc test.